Home > > > > > Report Detail

Global (United States, European Union and China) Tuberculosis Drug Market Research Report 2019-2025

Publisher Name :
Date: 29-Jul-2019
No. of pages: 112
Inquire Before Buying

Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are not identifiable in case of latent tuberculosis, due to presence of an inactive form of bacteria. In active tuberculosis, symptoms are clearly visible and they can spread from one person to another. Coughing for more than two weeks, chest pain, coughing up blood, chills, fatigue, unintentional weight loss, fever, and loss of appetite are some of the common symptoms of active tuberculosis. HIV/AIDS, severe kidney disease, cancer, diabetes, and malnutrition are some of the key risk factors generally found to be associated with tuberculosis.

Growing prevalence of multi-drug resistant tuberculosis is driving the tuberculosis drugs market. Drug shortages is a major restraint for the tuberculosis drugs market, especially in low- to medium-income countries of the world. Tuberculosis associated with diseases such as HIV/AIDS and conditions such as obesity is extremely difficult to manage. The tuberculosis drugs market can be segmented based on drug class, disease type, end-user, and region. In terms of drug class, the market can be categorized into first-line therapy, second-line therapy, and combination therapy. Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy. Second-line therapy is expected to be a rapidly growing segment of the tuberculosis drugs market.

In 2019, the market size of Tuberculosis Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tuberculosis Drug.

This report studies the global market size of Tuberculosis Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Tuberculosis Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Lupin

- Otsuka Novel Products

- Pfizer

- Sanofi

- ...

Market Segment by Product Type

- First-line Anti-TB Drugs

- Second-line Anti-TB Drugs

Market Segment by Application

- Active TB

- Latent TB

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Tuberculosis Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Tuberculosis Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Tuberculosis Drug are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Tuberculosis Drug Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tuberculosis Drug Market Size Growth Rate by Type (2019-2025)
1.3.2 First-line Anti-TB Drugs
1.3.3 Second-line Anti-TB Drugs
1.4 Market Segment by Application
1.4.1 Global Tuberculosis Drug Market Share by Application (2019-2025)
1.4.2 Active TB
1.4.3 Latent TB
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Drug Market Size
2.1.1 Global Tuberculosis Drug Revenue 2014-2025
2.1.2 Global Tuberculosis Drug Sales 2014-2025
2.2 Tuberculosis Drug Growth Rate by Regions
2.2.1 Global Tuberculosis Drug Sales by Regions 2014-2019
2.2.2 Global Tuberculosis Drug Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers 2014-2019
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2014-2019)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Key Manufacturers Tuberculosis Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tuberculosis Drug Market
3.6 Key Manufacturers Tuberculosis Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 First-line Anti-TB Drugs Sales and Revenue (2014-2019)
4.1.2 Second-line Anti-TB Drugs Sales and Revenue (2014-2019)
4.2 Global Tuberculosis Drug Sales Market Share by Type
4.3 Global Tuberculosis Drug Revenue Market Share by Type
4.4 Tuberculosis Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tuberculosis Drug Sales by Application
6 United States
6.1 United States Tuberculosis Drug Breakdown Data by Company
6.2 United States Tuberculosis Drug Breakdown Data by Type
6.3 United States Tuberculosis Drug Breakdown Data by Application
7 European Union
7.1 European Union Tuberculosis Drug Breakdown Data by Company
7.2 European Union Tuberculosis Drug Breakdown Data by Type
7.3 European Union Tuberculosis Drug Breakdown Data by Application
8 China
8.1 China Tuberculosis Drug Breakdown Data by Company
8.2 China Tuberculosis Drug Breakdown Data by Type
8.3 China Tuberculosis Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Tuberculosis Drug Breakdown Data by Company
9.2 Rest of World Tuberculosis Drug Breakdown Data by Type
9.3 Rest of World Tuberculosis Drug Breakdown Data by Application
9.4 Rest of World Tuberculosis Drug Breakdown Data by Countries
9.4.1 Rest of World Tuberculosis Drug Sales by Countries
9.4.2 Rest of World Tuberculosis Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Lupin
10.1.1 Lupin Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.1.4 Tuberculosis Drug Product Introduction
10.1.5 Lupin Recent Development
10.2 Otsuka Novel Products
10.2.1 Otsuka Novel Products Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.2.4 Tuberculosis Drug Product Introduction
10.2.5 Otsuka Novel Products Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.3.4 Tuberculosis Drug Product Introduction
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.4.4 Tuberculosis Drug Product Introduction
10.4.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tuberculosis Drug Sales Channels
11.2.2 Tuberculosis Drug Distributors
11.3 Tuberculosis Drug Customers
12 Market Forecast
12.1 Global Tuberculosis Drug Sales and Revenue Forecast 2019-2025
12.2 Global Tuberculosis Drug Sales Forecast by Type
12.3 Global Tuberculosis Drug Sales Forecast by Application
12.4 Tuberculosis Drug Forecast by Regions
12.4.1 Global Tuberculosis Drug Sales Forecast by Regions 2019-2025
12.4.2 Global Tuberculosis Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Tuberculosis Drug Product Picture
Table Tuberculosis Drug Key Market Segments
Table Major Manufacturers Tuberculosis Drug Covered in This Report
Table Global Tuberculosis Drug Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Tuberculosis Drug Sales Market Shar by Type 2014-2025
Figure First-line Anti-TB Drugs Figures
Table Major Manufacturers of First-line Anti-TB Drugs
Figure Second-line Anti-TB Drugs Figures
Table Major Manufacturers of Second-line Anti-TB Drugs
Table Global Tuberculosis Drug Market Share by Application 2019-2025 (K MT)
Figure Active TB Use Case
Figure Latent TB Use Case
Figure Tuberculosis Drug Report Years Considered
Figure Global Tuberculosis Drug Market Size 2014-2025 (Million US$)
Figure Global Tuberculosis Drug Sales 2014-2019 (K MT)
Table Global Tuberculosis Drug Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Tuberculosis Drug Sales by Regions 2014-2019 (K MT)
Table Global Tuberculosis Drug Sales Market Share by Regions 2014-2019
Figure Global Tuberculosis Drug Sales Market Share by Regions 2014-2019
Figure Global Tuberculosis Drug Sales Market Share by Regions in 2019
Table Global Tuberculosis Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Tuberculosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Tuberculosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Tuberculosis Drug Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Tuberculosis Drug Sales by Manufacturers (2014-2019) (K MT)
Table Global Tuberculosis Drug Sales Share by Manufacturers (2014-2019)
Figure Global Tuberculosis Drug Sales Share by Manufacturers in 2019
Table Tuberculosis Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Tuberculosis Drug Revenue Share by Manufacturers (2014-2019)
Figure Tuberculosis Drug Value Share by Manufacturers in 2019
Table Global Tuberculosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Tuberculosis Drug Price (2014-2019) (USD/MT)
Table Key Manufacturers Tuberculosis Drug Plants/Factories Distribution
Table Key Manufacturers Tuberculosis Drug Area Served
Table Date of Key Manufacturers Enter into Tuberculosis Drug Market
Table Key Manufacturers Tuberculosis Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global First-line Anti-TB Drugs Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Second-line Anti-TB Drugs Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Tuberculosis Drug Sales by Type (2014-2019) (K MT)
Table Global Tuberculosis Drug Sales Share by Type (2014-2019)
Figure Global Tuberculosis Drug Sales Market Share by Type (2014-2019)
Figure Global Tuberculosis Drug Sales Market Share by Type in 2018
Table Global Tuberculosis Drug Revenue by Type (2014-2019) (Million US$)
Table Global Tuberculosis Drug Revenue Share by Type (2014-2019)
Figure Global Tuberculosis Drug Revenue Market Share by Type (2014-2019)
Figure Global Tuberculosis Drug Revenue Market Share by Type in 2018
Table Tuberculosis Drug Price by Type 2014-2019 (USD/MT)
Table Global Tuberculosis Drug Sales by Application (2014-2019) (K MT)
Table Global Tuberculosis Drug Sales Share by Application (2014-2019)
Figure Global Sales Tuberculosis Drug Market Share by Application (2014-2019)
Figure Global Sales Tuberculosis Drug Market Share by Application (2014-2019)
Figure United States Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure United States Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table United States Tuberculosis Drug Sales by Company (2014-2019) (K MT)
Table United States Tuberculosis Drug Sales Market Share by Company (2014-2019)
Figure United States Tuberculosis Drug Sales Market Share by Company in 2019
Table United States Tuberculosis Drug Sales by Type (2014-2019) (K MT)
Table United States Tuberculosis Drug Sales Market Share by Type (2014-2019)
Figure United States Tuberculosis Drug Market Share by Type in 2019
Table United States Tuberculosis Drug Sales by Application (2014-2019) (K MT)
Table United States Tuberculosis Drug Sales Market Share by Application (2014-2019)
Figure United States Tuberculosis Drug Market Share by Application in 2019
Figure European Union Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure European Union Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Tuberculosis Drug Sales by Company (2014-2019) (K MT)
Table European Union Tuberculosis Drug Sales Market Share by Company (2014-2019)
Figure European Union Tuberculosis Drug Sales Market Share by Company in 2019
Table European Union Tuberculosis Drug Sales by Type (2014-2019) (K MT)
Table European Union Tuberculosis Drug Sales Market Share by Type (2014-2019)
Figure 2018 European Union Tuberculosis Drug Market Share by Type
Table European Union Tuberculosis Drug Sales by Application (2014-2019) (K MT)
Table European Union Tuberculosis Drug Sales Market Share by Application (2014-2019)
Figure 2018 European Union Tuberculosis Drug Market Share by Application
Figure China Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure China Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table China Tuberculosis Drug Sales by Company (2014-2019) (K MT)
Table China Tuberculosis Drug Sales Market Share by Company (2014-2019)
Figure China Tuberculosis Drug Sales Market Share by Company in 2019
Table China Tuberculosis Drug Sales by Type (2014-2019) (K MT)
Table China Tuberculosis Drug Sales Market Share by Type (2014-2019)
Figure China Tuberculosis Drug Market Share by Type in 2019
Table China Tuberculosis Drug Sales by Application (2014-2019) (K MT)
Table China Tuberculosis Drug Sales Market Share by Application (2014-2019)
Figure China Tuberculosis Drug Market Share by Application in 2019
Figure Rest of World Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure Rest of World Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Tuberculosis Drug Sales by Company (2014-2019) (K MT)
Table Rest of World Tuberculosis Drug Sales Market Share by Company (2014-2019)
Figure Rest of World Tuberculosis Drug Sales Market Share by Company in 2019
Table Rest of World Tuberculosis Drug Sales by Type (2014-2019) (K MT)
Table Rest of World Tuberculosis Drug Sales Market Share by Type (2014-2019)
Figure Rest of World Tuberculosis Drug Market Share by Type in 2019
Table Rest of World Tuberculosis Drug Sales by Application (2014-2019) (K MT)
Table Rest of World Tuberculosis Drug Sales Market Share by Application (2014-2019)
Figure Rest of World Tuberculosis Drug Market Share by Application in 2019
Table Rest of World Tuberculosis Drug Sales by Countries (2014-2019) (K MT)
Table Rest of World Tuberculosis Drug Sales Market Share by Countries (2014-2019)
Figure Rest of World Tuberculosis Drug Sales Market Share by Countries in 2019
Table Rest of World Tuberculosis Drug Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Tuberculosis Drug Revenue Market Share by Countries (2014-2019)
Figure Rest of World Tuberculosis Drug Revenue Market Share by Countries in 2019
Figure Japan Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Japan Tuberculosis Drug Revenue Growth Rate (2014-2019) (K MT)
Figure Korea Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Korea Tuberculosis Drug Revenue Growth Rate (2014-2019) (K MT)
Figure India Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure India Tuberculosis Drug Revenue Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Tuberculosis Drug Revenue Growth Rate (2014-2019) (K MT)
Table Lupin Company Details
Table Lupin Description and Business Overview
Table Lupin Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Lupin Tuberculosis Drug Sales Growth Rate (2014-2019)
Table Lupin Tuberculosis Drug Sales Market Share in Global Market
Table Lupin Recent Development
Table Otsuka Novel Products Company Details
Table Otsuka Novel Products Description and Business Overview
Table Otsuka Novel Products Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Otsuka Novel Products Tuberculosis Drug Sales Growth Rate (2014-2019)
Table Otsuka Novel Products Tuberculosis Drug Sales Market Share in Global Market
Table Otsuka Novel Products Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Tuberculosis Drug Sales Growth Rate (2014-2019)
Table Pfizer Tuberculosis Drug Sales Market Share in Global Market
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Tuberculosis Drug Sales Growth Rate (2014-2019)
Table Sanofi Tuberculosis Drug Sales Market Share in Global Market
Table Sanofi Recent Development
Figure Tuberculosis Drug Value Chain
Table Tuberculosis Drug Distributors List
Table Tuberculosis Drug Customers List
Table Global Tuberculosis Drug Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure Global Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Tuberculosis Drug Sales Forecast by Type 2019-2025 (K MT)
Figure Global Tuberculosis Drug Sales Forecast by Type 2019-2025 (K MT)
Figure Global Tuberculosis Drug Sales Market Share Forecast by Type 2019-2025
Table Global Tuberculosis Drug Sales Forecast by Application 2019-2025 (K MT)
Figure Global Tuberculosis Drug Sales Forecast by Application 2019-2025 (K MT)
Figure Global Tuberculosis Drug Sales Market Share Forecast by Application 2019-2025
Table Global Tuberculosis Drug Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Tuberculosis Drug Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Tuberculosis Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Tuberculosis Drug Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Tuberculosis Drug Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Tuberculosis Drug Revenue Market Share Forecast by Regions 2019-2025
Figure United States Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure United States Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Figure European Union Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure European Union Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Figure China Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure China Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Figure Japan Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure Japan Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Figure Korea Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure Korea Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Figure India Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure India Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Tuberculosis Drug Sales Forecast 2019-2025 (K MT)
Figure Southeast Asia Tuberculosis Drug Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Tuberculin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Tuberculin market size was valued at US$ 270 million in 2023. With growing demand in downstream market, the Tuberculin is forecast to a readjusted size of US$ 384.7 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Tuberculin market. Tuberculin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Tuberculin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 98
    According to our (Global Info Research) latest study, the global Tuberculin market size was valued at USD 284 million in 2023 and is forecast to a readjusted size of USD 393.9 million by 2030 with a CAGR of 4.8% during review period. Tuberculin, also known as purified protein derivative is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. Injection is done into the ......
  • Pyrazinamide - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    The global Pyrazinamide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pyrazinamide in various end use industries. The expanding demands from the Children and Adult, are propelling Pyrazinamide market. Purity 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity 99% segment is estima......
  • Ethambutol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 105
    The global Ethambutol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ethambutol in various end use industries. The expanding demands from the Chemical Industry and Pharmaceutical Industry, are propelling Ethambutol market. Reagent Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Medi......
  • Global Pyrazinamide Professional Survey Report 2023, Forecast to 2028
    Published: 14-Dec-2023        Price: US 3280 Onwards        Pages: 130
    Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol. It is not generally recommended for the treatment of latent tuberculosis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. ......
  • Global Pyrazinamide Market Research Report 2023, Forecast to 2028
    Published: 14-Dec-2023        Price: US 2680 Onwards        Pages: 162
    Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol. It is not generally recommended for the treatment of latent tuberculosis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. ......
  • Global Ethambutol Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global Ethambutol market: According to our latest research, the global Ethambutol market looks promising in the next 5 years. As of 2022, the global Ethambutol market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Ethambutol market, with a systematical de......
  • Global Isoniazid Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Isoniazid market: According to our latest research, the global Isoniazid market looks promising in the next 5 years. As of 2022, the global Isoniazid market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Isoniazid market, with a systematical descri......
  • Global Isoniazid Market Research Report 2023
    Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 90
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Isoniazid market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - AMSAL CHEM - Resonance Specialties - Calyx Pharma & Chem - Camus pharma - Titan Pharma (India) - Taizhou Tianrui Pharmaceutical - Zhejiang Second Pha......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs